PHASE-I TRIAL OF A DIPHTHERIA-TOXIN (DT) FUSION PROTEIN (DAB(389)IL-2) FOR THE TREATMENT OF INTERLEUKIN-2 RECEPTOR (IL-2R) EXPRESSING HEMATOLOGIC NEOPLASMS

Authors
KUZEL T FOSS F LEMAISTRE C PLATANIAS L RATAIN M ROOK A SALEH M SCHWARTZ G NICHOLS J
Citation
T. Kuzel et al., PHASE-I TRIAL OF A DIPHTHERIA-TOXIN (DT) FUSION PROTEIN (DAB(389)IL-2) FOR THE TREATMENT OF INTERLEUKIN-2 RECEPTOR (IL-2R) EXPRESSING HEMATOLOGIC NEOPLASMS, Blood, 86(10), 1995, pp. 1081-1081
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
1081 - 1081
Database
ISI
SICI code
0006-4971(1995)86:10<1081:PTOAD(>2.0.ZU;2-B